Exchange: OTC Sector: Healthcare Industry: Health Information Services
0.00% $0.0005
America/New_York / 26 des 2023 @ 15:31
FUNDAMENTALS | |
---|---|
MarketCap: | 0.0481 mill |
EPS: | -0.0400 |
P/E: | -0.0100 |
Earnings Date: | Apr 01, 2024 |
SharesOutstanding: | 96.13 mill |
Avg Daily Volume: | 0 mill |
RATING 2024-01-16 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/21 | 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | |
Revenue | n/a | n/a | n/a | n/a | n/a | |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | |
Ebit | ||||||
Asset | ||||||
Debt | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.0100 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.00x |
Company: PE -0.0100 | industry: PE 55.39 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ -0.0255 - 0.0265 ( +/- 5 200.00%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-12-16 | Wolf James G. | Buy | 33 700 | Common Stock, $0.01 par value |
2022-12-15 | Wolf James G. | Buy | 85 100 | Common Stock, $0.01 par value |
2022-12-14 | Wolf James G. | Buy | 136 200 | Common Stock, $0.01 par value |
2022-11-21 | Wolf James G. | Buy | 24 700 | Common Stock, $0.01 par value |
2022-11-17 | Wolf James G. | Buy | 300 | Common Stock, $0.01 par value |
INSIDER POWER |
---|
99.70 |
Last 44 transactions |
Buy: 5 973 078 | Sell: 6 634 389 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.0005 (0.00% ) |
Volume | 0.0200 mill |
Avg. Vol. | 0 mill |
% of Avg. Vol | 0 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Healthtech Solutions, Inc., through its subsidiaries, operates as a life sciences company. It focuses on the development of wound care products for acute and chronic wounds, including AmnioBind, a placental membrane allograft for burns and non-healing wounds, such as diabetic foot ulcers. The company also engages in the development of ultrasound imaging and artificial intelligence-based image analysis software for the applications in treatment of chest and musculoskeletal system. In addition, it is developing software technology that compares a healthy heart rhythm electronic signal with a damaged heart's signal that derives an electronic signal representing the curative waveform. The company was founded in 2018 and is based in Tuckahoe, New York.